Another Multiple Sclerosis Winner for Biogen

In this video, health-care analyst David Williamson discusses Biogen's latest drug up for FDA approval.

http://www.fool.com/investing/general/2013/05/21/another-new-multiple-sclerosis-drug-for-biogen.aspx